West Nile virus infection does not induce PKR activation in rodent cells

Virology

Volumn 421, Issue 1, 2011, Pages 51-60

  Elbahesh, H ^a,b   Scherbik, S V ^a   Brinton, M A ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b St Jude Children's Research Hospital   (United States)

Author keywords

DsRNA; EIF2a; Nck; PKR; West Nile virus

Indexed keywords

INITIATION FACTOR 2; MESSENGER RNA; NCK PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE R; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; VIRUS INFECTION; VIRUS STRAIN; WEST NILE FLAVIVIRUS;

ANIMALS; CELL LINE; CRICETINAE; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PHOSPHORYLATION; RODENT DISEASES; RODENTIA; WEST NILE FEVER; WEST NILE VIRUS;

RODENTIA; WEST NILE VIRUS;

EID: 80055067167     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.08.008     Document Type: Article

References (60)

1. Arnaud N., Dabo S., Maillard P., Budkowska A., Kalliampakou K.I., Mavromara P., Garcin D., Hugon J., Gatignol A., Akazawa D., Wakita T., Meurs E.F. Hepatitis C virus controls interferon production through PKR activation. PLoS One 2010, 5:e10575.
2. Brinton M.A. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 2002, 56:371-402.
3. Cardin E., Larose L. Nck-1 interacts with PKR and modulates its activation by dsRNA. Biochem. Biophys. Res. Commun. 2008, 377:231-235.
4. Cardin E., Latreille M., Khoury C., Greenwood M.T., Larose L. Nck-1 selectively modulates eIF2alphaSer51 phosphorylation by a subset of eIF2alpha-kinases. FEBS J. 2007, 274:5865-5875.
5. Conn G.L. Expression of active RNA-activated protein kinase (PKR) in bacteria. Biotechniques 2003, 35(682-684):686.
6. Davis W.G., Blackwell J.L., Shi P.Y., Brinton M.A. Interaction between the cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J. Virol. 2007, 81:10172-10187.
7. Dong H., Zhang B., Shi P.Y. Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein. Virology 2008, 381:123-135.
8. Donze O., Abbas-Terki T., Picard D. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 2001, 20:3771-3780.
9. Emara M.M., Brinton M.A. Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9041-9046.
10. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70:1032-1060.
11. Garcia M.A., Meurs E.F., Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007, 89:799-811.
12. Gilfoy F.D., Mason P.W. West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J. Virol. 2007, 81:11148-11158.
13. Gillespie L.K., Hoenen A., Morgan G., Mackenzie J.M. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 2010, 84:10438-10447.
14. Gubler D.J., Kuno G., Markoff J. Flaviviruses. Fields Virology 2007, 1153-1252. Lippincott Williams and Wilkins, Philadelphia. M. David, P.M.H. Knipe (Eds.).
15. He B., Gross M., Roizman B. The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J. Biol. Chem. 1998, 273:20737-20743.
16. Hebner C.M., Wilson R., Rader J., Bidder M., Laimins L.A. Human papillomaviruses target the double-stranded RNA protein kinase pathway. J. Gen. Virol. 2006, 87:3183-3193.
17. Hershey J.W. Translational control in mammalian cells. Annu. Rev. Biochem. 1991, 60:717-755.
18. Ito T., Yang M., May W.S. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 1999, 274:15427-15432.
19. Jammi N.V., Beal P.A. Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity. Nucleic Acids Res. 2001, 29:3020-3029.
20. Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., Block T.M., Guo J.T. Identification of five interferon-induced cellular proteins that inhibit west Nile virus and dengue virus infections. J. Virol. 2010, 84:8332-8341.
21. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999, 13:1211-1233.
22. Langland J.O., Jacobs B.L. Cytosolic double-stranded RNA-dependent protein kinase is likely a dimer of partially phosphorylated Mr=66,000 subunits. J. Biol. Chem. 1992, 267:10729-10736.
23. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006, 119:100-110.
24. Latreille M., Larose L. Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress. J. Biol. Chem. 2006, 281:26633-26644.
25. Lee T.G., Tomita J., Hovanessian A.G., Katze M.G. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:6208-6212.
26. Lemaire P.A., Lary J., Cole J.L. Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J. Mol. Biol. 2005, 345:81-90.
27. Lin K.C., Chang H.L., Chang R.Y. Accumulation of a 3'-terminal genome fragment in Japanese encephalitis virus-infected mammalian and mosquito cells. J. Virol. 2004, 78:5133-5138.
28. Lindenbach B.D., Thiel H.J., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2007, 1101-1152. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
29. Lopez-Lastra M., Ramdohr P., Letelier A., Vallejos M., Vera-Otarola J., Valiente-Echeverria F. Translation initiation of viral mRNAs. Rev. Med. Virol. 2010, 20:177-195.
30. Mackenzie J. Wrapping things up about virus RNA replication. Traffic 2005, 6:967-977.
31. MacQuillan G.C., Caterina P., de Boer B., Allan J.E., Platten M.A., Reed W.D., Jeffrey G.P. Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus disease. J. Mol. Histol. 2009, 40:171-176.
32. Majumdar R., Maitra U. Regulation of GTP hydrolysis prior to ribosomal AUG selection during eukaryotic translation initiation. EMBO J. 2005, 24:3737-3746.
33. McKenna S.A., Kim I., Liu C.W., Puglisi J.D. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs. J. Mol. Biol. 2006, 358:1270-1285.
34. McKenna S.A., Lindhout D.A., Shimoike T., Aitken C.E., Puglisi J.D. Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. J. Mol. Biol. 2007, 372:103-113.
35. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62:379-390.
36. Nallagatla S.R., Bevilacqua P.C. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 2008, 14:1201-1213.
37. Nallagatla S.R., Hwang J., Toroney R., Zheng X., Cameron C.E., Bevilacqua P.C. 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 2007, 318:1455-1458.
38. Nanduri S., Carpick B.W., Yang Y., Williams B.R., Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 1998, 17:5458-5465.
39. Nanduri S., Rahman F., Williams B.R., Qin J. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J. 2000, 19:5567-5574.
40. Pang Q., Christianson T.A., Keeble W., Koretsky T., Bagby G.C. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J. Biol. Chem. 2002, 277:49638-49643.
41. Patel C.V., Handy I., Goldsmith T., Patel R.C. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 2000, 275:37993-37998.
42. Pijlman G.P., Funk A., Kondratieva N., Leung J., Torres S., van der Aa L., Liu W.J., Palmenberg A.C., Shi P.Y., Hall R.A., Khromykh A.A. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008, 4:579-591.
43. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. (Maywood) 2003, 228:111-133.
44. Romano P.R., Garcia-Barrio M.T., Zhang X., Wang Q., Taylor D.R., Zhang F., Herring C., Mathews M.B., Qin J., Hinnebusch A.G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol. Cell. Biol. 1998, 18:2282-2297.
45. Scherbik S.V., Paranjape J.M., Stockman B.M., Silverman R.H., Brinton M.A. RNase L plays a role in the antiviral response to West Nile virus. J. Virol. 2006, 80:2987-2999.
46. Sharp T.V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C.G., Hilse K., Clemens M.J. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 1993, 21:4483-4490.
47. Shimoike T., McKenna S.A., Lindhout D.A., Puglisi J.D. Translational insensitivity to potent activation of PKR by HCV IRES RNA. Antiviral Res. 2009, 83:228-237.
48. Spurgeon M.E., Ornelles D.A. The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection. J. Virol. 2009, 83:9970-9982.
49. Su Q., Wang S., Baltzis D., Qu L.K., Wong A.H., Koromilas A.E. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:63-68.
50. Su Q., Wang S., Baltzis D., Qu L.K., Raven J.F., Li S., Wong A.H., Koromilas A.E. Interferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2. EMBO Rep. 2007, 8:265-270.
51. Sudhakar A., Ramachandran A., Ghosh S., Hasnain S.E., Kaufman R.J., Ramaiah K.V. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000, 39:12929-12938.
52. Tan S.L., Tareen S.U., Melville M.W., Blakely C.M., Katze M.G. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. J. Biol. Chem. 2002, 277:36109-36117.
53. Tanaka H., Samuel C.E. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:7995-7999.
54. Toth A.M., Zhang P., Das S., George C.X., Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 2006, 81:369-434.
55. Urosevic N., van Maanen M., Mansfield J.P., Mackenzie J.S., Shellam G.R. Molecular characterization of virus-specific RNA produced in the brains of flavivirus-susceptible and -resistant mice after challenge with Murray Valley encephalitis virus. J. Gen. Virol. 1997, 78(Pt 1):23-29.
56. Vaheri A., Sedwick W.D., Plotkin S.A., Maes R. Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology 1965, 27:239-241.
57. Welsch S., Miller S., Romero-Brey I., Merz A., Bleck C.K., Walther P., Fuller S.D., Antony C., Krijnse-Locker J., Bartenschlager R. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 2009, 5:365-375.
58. Yamshchikov V.F., Wengler G., Perelygin A.A., Brinton M.A., Compans R.W. An infectious clone of the West Nile flavivirus. Virology 2001, 281:294-304.
59. Yin Z., Haynie J., Williams B.R., Yang Y.C. C114 is a novel IL-11-inducible nuclear double-stranded RNA-binding protein that inhibits protein kinase R. J. Biol. Chem. 2003, 278:22838-22845.
60. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31:3406-3415.